Screener
HIBL vs LABD
Direxion Daily S&P 500 High Beta Bull 3X Shares vs Direxion Daily S&P Biotech Bear 3X Shares
Key differences
- HIBL costs 0.09% less per year.
- HIBL follows a leveraged strategy; LABD uses inverse.
- Over the last 3 years, HIBL has delivered higher annualized returns.
Side-by-side comparison
| HIBL | LABD | |
|---|---|---|
| Annual cost (TER) | 0.98% | 1.07% |
| Fund size (AUM) | $83M | $69M |
| Since | 2019 | 2015 |
| Dividend yield | 1.66% | 6.38% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | leveraged | inverse |
| CAGR 1Y | +242.4% | -82.9% |
| CAGR 3Y | +60.5% | -50.8% |
| CAGR 5Y | +8.7% | -42.0% |
| Sharpe 3Y | 0.96 | -0.52 |
| Volatility 1Y | 66.14% | 74.72% |
| Max drawdown | -88.27% | -99.98% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to HIBL and LABD
Explore further